Objective To determine the feasibility of long-term prospective follow-up and ascertainment of cancer in offspring and mothers from the 1993–1995 Chinese Community Intervention Program that provided folic acid supplements before and during early pregnancy to reduce neural tube defects.
Design Feasibility pilot study for a prospective cohort study.
Setting Families residing during 2012–2013 in one rural and one urban county from 21 counties in 3 provinces in China included in the Community Intervention Program campaign.
Participants The feasibility study targeted 560 families, including 280 from the rural and 280 from the urban county included in the large original study; about half of mothers in each group had taken and half had not taken folic acid supplements.
Intervention The planned new study is observational.
Primary and secondary outcome measures Primary: incidence of paediatric cancers in offspring; secondary: other chronic diseases in offspring and chronic diseases in mothers
Results Only 3.4% of pilot study families could not be found, 3.9% had moved out of the study area and 8.8% refused to participate. Interviews were completed by 82% of mothers, 79% of fathers and 83% of offspring in the 560 families. Almost all mothers and offspring who were interviewed also participated in anthropometric measurements. We found notable urban–rural differences in sociodemographic and lifestyle characteristics of the parents, but fewer differences among the offspring. In eight catchment area hospitals, we identified a broad range of paediatric cancers diagnosed during 1994–2013, although paediatric brain tumours, lymphomas and rarer cancers were likely under-represented.
Conclusions Overall, 20 years after the original Community Intervention Program, the pilot study achieved high levels of follow-up and family member interview participation, and identified substantial numbers of paediatric malignancies during 1994–2013 in catchment area hospitals. Next steps and strategies for overcoming limitations are described.
- folic acid supplements
- pediatric cancer
- pilot study
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Strengths and limitations of this study
In the pilot study, high proportions of Chinese Community Intervention Program (CIP) mothers, fathers and offspring were traced, identified and participated in interviews and anthropometric measurements.
Incomplete ascertainment of incident paediatric cancers in the CIP offspring is likely in the absence of long-standing population-based cancer registries of high quality in the geographic region where the intervention was carried out.
Reduction of the small proportion of the CIP pilot study subjects who could not be traced or identified, or would not participate in interviews or anthropometric measurements will be challenging, particularly for those pilot study offspring (and parents) who have moved out of the CIP catchment area.
Environmental factors and gene–environment interactions during the periconceptional, prenatal and early-life periods are increasingly linked with cancer and other serious diseases during childhood, adolescence and adulthood, but research is limited and mechanisms are poorly understood.1 2 Support for the in utero origin of paediatric leukaemia, mostly acute lymphoblastic leukaemia, has been provided by observations on twins showing that the chromosomal rearrangements seen in leukaemia cases could occur in utero, coupled with work demonstrating that certain chromosomal translocations are present in the blood spot cards of children who later developed childhood acute lymphoblastic leukaemia with the same translocations.3 The only established risk factors for paediatric cancer (eg, ionising radiation, a few genetic or congenital syndromes and birth weight)4 explain <20% of occurrence.5 6 Modest increased7–10 or reduced risks11 12 have recently been linked with other exposures in pooled paediatric leukaemia case–control studies. Prospects for prevention are limited to avoidance of ionising radiation or high birth weight, although more recently periconceptional folic acid (FA) supplements have been linked with reduced risks in a large pooled analysis.11 However, results for the association of periconceptional or prenatal FA supplements and paediatric leukaemia have been inconsistent in individual studies, and these inconsistencies and the modest associations observed in the pooled analysis may be due in part to differential or inaccurate long-term recall,13 14 selection bias15 and declining participation rates, and growing socioeconomic differences between control and case subjects.16–18 Prospective large epidemiological studies could overcome many of these limitations.
A unique opportunity to evaluate the potential role of FA supplements before and during early pregnancy in reducing risk of paediatric leukaemia in offspring was identified 20 years after a 1993–1995 Community Intervention Program (CIP) in which FA supplements before and during early pregnancy were provided in 21 Chinese counties to reduce neural tube defects (NTD). Among offspring of 130 142 women who took 400 µg FA supplements compared with offspring of the 117 689 women who did not take FA supplements, there was a 79% and 41% reduction in the prevalence of NTD in high (northeast) and lower (southeast) rate regions, respectively.19 Extensive information had been collected during 1993–1995 on maternal sociodemographic, lifestyle, reproductive, medical conditions and treatments, occupational and other factors during the periconceptional and prenatal periods, and on offspring during the early neonatal period.
We conducted a pilot study to assess the feasibility of: (1) establishing a large cohort (designated the Children and Families Cohort Study (CFCS)) from the CIP families for planned prospective epidemiological studies evaluating paediatric leukaemia and other health outcomes in offspring and mothers; (2) collecting data from two generations of family members by interview and anthropometric measurements; and (3) identifying and validating paediatric cancers diagnosed during 1994–2013 in the CIP catchment area among children who are potentially eligible CIP offspring.
Study team organisation and approvals
In 2012–2013, investigators from the Chinese Center for Disease Control and Prevention (China CDC), US Centers for Disease Control and Prevention (US CDC), the US National Cancer Institute (NCI), the Maternal and Child Health (MCH) Hospital leaders of each county and clinicians of the hospitals selected for identification of paediatric cancers conducted data collection. The protocol was approved by the Chinese provincial, city, and county health bureaus, county MCH hospitals and other participating hospitals, and by the Chinese and US CDCs and US NCI ethics review committees (see details in Ethics Approval section following the Discussion).
Five hundred CIP families were targeted from two CIP geographic regions, for example, a rural county in the northeast and an urban county in the southeast. From the pregnancy-monitoring registration system, 280 families from each county were selected with eligibility criteria including: (1) mother resided and underwent a premarital or prenatal physical examination in the specified county during 1993–1995; (2) the pregnancy resulted in a live, single birth in the county by December 1996; (3) sex of the infant was known and (4) high-quality data on maternal use of FA supplements before and during the pregnancy were available.
Tracing and contacting families
County MCH staff verified the names, vital status, current addresses and phone numbers of eligible mothers and children selected by comparing the lists with township and village health service and New Rural Cooperative Insurance rosters. To improve recruitment, the county-level MCH, township hospital, village or community health service centre physicians, assisted by the village development and community/street committee staff, made initial contact with the families.
A letter describing the study purpose, questionnaire topics, physical measurements, confidentiality, benefits, potential risks, incentives and opportunity to opt out of all or part of the data collection was mailed or delivered in person. After letter delivery, the village or Township doctor contacted the mother/caretaker to answer questions and arranged a home visit where consent was obtained.
After a didactic 2-day training, interviewers practised questionnaire administration and taking anthropometric measurements. The training concluded with instructions on manual review and data editing. Approximately 1 month later, supervisory Chinese CDC staff again evaluated staff and retrained as needed.
Data collection: questionnaires
One of two maternal questionnaires assessed family residential characteristics and maternal sociodemographic characteristics, lifestyle, reproductive and medical history, and job history. If the child resided with a caretaker, a modified shorter questionnaire was administered. A second maternal/caretaker questionnaire asked about the offspring’s date of birth, vital status, history of cancer or birth defects, diagnosis of autism, developmental milestones, highest level of education and job history.
The offspring’s questionnaire asked date of birth, self-rating of physical health, source of medical care, number of non-routine health visits in the past 12 months, cigarette smoking and secondhand smoke history, use of alcohol and history of pubertal changes.
The father’s questionnaire inquired about date of birth, education, marital status, job history, smoking and secondhand smoking, alcohol use and medical history.
Other data collection (results reported separately)
After the interviews, offspring and mothers were invited to participate in anthropometric measurements at the Township hospitals. At the end of questionnaire and anthropometric measurements data collection, the participants received appreciation certificates and incentives. A letter was also provided indicating that the participant might be contacted for a second study to assess diet, nutrition, physical activity and ultraviolet radiation exposure.
Identification and validation of paediatric cancer cases
In consultation with hospitals and community leaders, eight hospitals providing different levels of services were selected from study regions and major cities near to the catchment area where CIP children might have been referred for diagnosis and treatment of paediatric cancer. A workshop was held with experts in paediatric haematology, oncology and neurosurgery from these hospitals to develop the methods for identification and validation of the paediatric cancer outcomes.
The medical record review process included: (1) searching for medical records to identify all paediatric patients with cancer born during 1994–1996 who were diagnosed and/or treated during 1994–2013; (2) developing a list of all potentially eligible patients (born during 1994–1996 in the 21 counties included in the CIP or, if no specific place of birth was listed, those born in the three provinces in which the 21 counties were geographically located); (3) obtaining and abstracting medical records of these patients; and (4) independent reviewing of the abstract forms by two clinical experts with resolution of differences through discussion to determine a final diagnosis. For quality control purposes, each hospital was visited at least once by China CDC staff to evaluate procedures. In the absence of re-identification of the entire CIP cohort and comprehensive population-based cancer registries, it was not possible to link the paediatric cancer cases identified in hospitals with the cohort.
A data management training workshop was held in Beijing for China CDC staff followed by a detailed review and editing of the data collected. All forms were coded, checked, entered twice and data verified for accuracy. Range and logic sequences were verified against original paper forms and corrections made as required.
In data analysis conducted during 2016–2017, cross-tabulation was used to evaluate the distribution of demographic, socioeconomic, lifestyle, developmental and medical history characteristics by county. Fisher’s exact tests were used to test for urban versus rural geographic differences by covariates among mothers, offspring and fathers.
Subjects and public involvement
Subjects and the public were not involved in development of the research question, the study design, determination of the outcome measures to be studied, recruitment or conduct of the study. Subjects were informed about results of anthropometric measures and blood chemistry laboratory tests (methods for the laboratory test components of a second pilot study are reported elsewhere). Subjects also received physical activity monitors at the end of the physical activity monitoring component of the second pilot study (methods reported elsewhere).
If the full-scale study is funded, the findings would be shared with the subjects, public health officials and medical professionals through newsletters and other types of communication.
Of the 560 families selected for the pilot study, only 3% (2% in the rural and 5% in the urban centre) could not be found, 4% of families reportedly moved away (6% in the rural and 2% in the urban centre) and 9% (8% in the rural and 9% in the urban centre) refused to be contacted (table 1). Overall, 82% of mothers, 79% of fathers and 83% of offspring completed interviews of the 560 families selected. Among the 469 families (84% of the 560 selected) targeted for interviews (after excluding those who could not be found, had moved away or had refused to be contacted), the interview participation was very high, for example, 98% of mothers, 95% of fathers and 99% of offspring. Almost all mothers and offspring who were interviewed also participated in the anthropometric measurements (table 1). The proportion of mothers contacted who took FA supplements (49% in the rural centre and 52% in the urban centre) was similar to the 50% in each centre who took FA in the samples originally selected.
Nearly half of urban families resided 10 or fewer years in their current home, whereas 90% of rural families had lived >10 years in the current home (table 1). More than 93% of rural and urban families owned their current home. Close to half of the urban families compared with 21% of rural families had five or more persons recently residing in their residence.
Urban mothers were younger at the age of marriage registration, birth of the CIP offspring, and at the age of current interview completion (table 2). Rural mothers reported less education, held fewer jobs and a slightly higher proportion were married compared with urban mothers. Almost none of the rural and urban mothers reported smoking cigarettes. Rural mothers (43%) were somewhat more likely than urban mothers (33%) to report being exposed to secondhand smoke during their pregnancies for ≥3 days per week. Rural mothers (45%) were more likely than urban mothers (35%) to report that their offspring had been exposed to secondhand smoke ≥ 3 days per week before age 5 years. Few of the mothers (5% overall, 8% urban versus 1% rural) reported drinking alcohol. Rural mothers were more likely to report onset of menstrual periods at older ages, and 30% of rural compared with 16% of urban mothers reported only one pregnancy.
Rural fathers were older at the time of marriage registration, birth of their offspring and at the current interview compared with urban fathers (table 3). Rural fathers reported less education and fewer jobs compared with urban fathers. A higher proportion of rural (33%) compared with urban (19%) fathers reported never smoking, although rural fathers were more likely than urban fathers to be exposed to secondhand smoke for over 10 years before age 20. Urban (75%) compared with rural (60%) fathers were more likely to be currently smoking. Use of alcohol was similar between rural (63%) and urban (65%) fathers, but a somewhat higher proportion of urban (61%) than rural (57%) fathers reported alcohol use for ≥15 years.
Urban versus rural differences in sociodemographic factors were less apparent among offspring (table 4). The two groups were similar in birth year, age at interview, and sex distribution, but somewhat more urban than rural offspring reported living with their parents. Most in each group were full-time students, but urban offspring were more likely to report attending trade or technical school. Most offspring in both groups reported never smoking cigarettes regularly; a somewhat higher proportion of urban than rural offspring reported secondhand smoke exposure at home for ≥1 days per week and alcohol use for ≥1 days since birth.
Eight hospitals selected included county and provincial hospitals, children’s medical centres and referral hospitals in the nearby cities of Beijing (treating brain tumours), Tianjin (haematological disorders) and Shanghai (paediatric oncology) to which children would have been referred for definitive diagnosis and treatment of paediatric cancer (table 5). A broad range of incident paediatric malignancies and related disorders were identified in the eight hospitals; of the total cancers, 77% were designated by type and 23% were unspecified (table 4). Of the 137 paediatric cancers identified, 37% were leukaemias. Only 10% (13/137) of the paediatric neoplasms were brain tumours and 7% (9/137) were lymphomas, although similar numbers were identified in the earlier (1994–2003) and later (2004–2013) time periods. No retinoblastomas were identified.
In the pilot study of 580 CIP families, we located all but 3.4% of the families and only 8.7% refused to participate. Overall, 82% of mothers, 79% of fathers and 83% of offspring selected of the 560 families chosen completed interviews. More than 90% of those who agreed to be contacted completed interviews, and 99% of the mothers and offspring completed anthropometric measurements. We found notable differences in sociodemographic and lifestyle characteristics between rural and urban parents, but fewer differences in offspring. We identified a broad range of incident (1994–2013) paediatric cancers in the diverse hospitals, but there appeared to be incomplete ascertainment of paediatric brain tumours, lymphomas and certain others (retinoblastoma), and 23% were of unspecified subtype.
Supporting our findings of notable rural versus urban differences in parents, data since the 1990s from the National Bureau of Statistics of China have consistently shown significant differences between rural and urban areas in gross domestic product (GDP), per capita income and educational attainment.20 The two pilot study centres differed significantly in geography and urbanicity (rural northeast vs urban southeast regions), GDP (higher in southeast), principal industry (agricultural in the northeast vs high technology industry in the southeast) and greater in-migration in the southeast. Recently, household income, education and health status have been shown to account for the lower use of preventive care services by rural compared with urban residents.21 We also note significant differences in reported parity and gravidity, consistent with data reported at CIP enrolment in 1993–1995.
The lack of urban–rural differences reported by offspring may reflect adolescent lifestyle changes over time, as illustrated by a recent report on obesity among children in Shandong Province, China.22 The higher urban compared with rural prevalence of childhood overweight and obesity in Shandong during 1985–2005 no longer existed in 2014 due to the increasing prevalence of overweight and obesity among rural children over time, a change attributed to economic development and lifestyle changes in rural areas.
Strengths and limitations
Compared with many cohort studies, the proportion of families refusing to participate was relatively small, but strategies should be developed to further minimise refusals and entice higher participation. New strategies are needed to locate offspring who are increasingly likely to move away from their childhood residences for educational or employment opportunities. The ideal approach for identifying incident paediatric cancers in the Chinese Children and Families Cohort Study would have been linkage with population-based cancer registries, but there have been no long-standing population-based cancer registries of high quality in the geographic regions where the original CIP was carried out. Although the pilot study included different types of hospitals where children with paediatric cancer might be initially seen and treated, the likely incomplete ascertainment of certain cancer outcomes, a known problem described in compendia of international population-based cancer registry data,23 suggests the need for learning more about referral patterns for paediatric cancers. Focus groups of hospital and medical professional society leaders would be useful to discuss strategies for improving identification of paediatric cancer cases, particularly those diagnosed in earlier time periods. In the absence of comprehensive coverage of the geographic catchment area by high-quality population-based cancer registries, it is difficult to assess the likely success of matching cohort members with the paediatric cancer cases identified through the hospital component of the pilot study. A more expensive strategy would be to add active follow-up all offspring and parents to identify and verify incident paediatric cancers and to review death certificates to confirm those reported as deceased. In the absence of death certificates, particularly in the early time periods, verbal autopsy interviews may be needed.
Overall, the pilot study revealed positive results for re-identifying, tracing, interviewing and obtaining anthropometric measurements in the original CIP families to establish the new CFCS cohort. A larger feasibility study over a broader geographic region is needed to verify that the strategies used in the current pilot study would continue to yield success in tracing, locating and obtaining the high participation levels needed for cohort follow-up. The large number of paediatric cancers identified is also promising, but further work is needed to improve the level of ascertainment, and test the feasibility of matching paediatric cancers to the CIP children. If a larger feasibility study is successful, we propose to carry out a prospective record linkage CFCS to compare risk of paediatric leukaemia, brain tumours and other paediatric cancers in offspring of 130 142 Chinese mothers who took vs offspring of 117 689 mothers who did not take FA supplements before and during early pregnancy in the 1993–1995 CIP to complement case–control study findings of reduced risks of childhood leukaemia associated with mothers’ periconceptional use of FA. In addition, the new CFCS cohort would be a valuable scientific resource that could evaluate a wide range of exposures and outcomes, and address many important research questions once assembled.
The authors are indebted to the county and township-level Maternal and Child Health hospitals nurses and physicians who interviewed the family members; the Maternal Child Health township hospitals, village and community development and community/street committee staff who made the initial contact with the selected families; the hospital and community leaders who identified the eight hospitals included in the pilot study; and the hospital directors, department chairs, senior haematologists, oncologists, neurosurgeons and numerous other medical staff who supported the hospital component with identification and abstraction of medical records of incident pediatric cancer cases. They also thank the families who participated in the feasibility study. They express appreciation to IMS, Inc. computer programmers for preparation of data files and computing support.
MSL and LW contributed equally.
Contributors MSL, LW, RJB, AC, LH, LF, ZL, NP, CMK, XL, JS and YW: study concept and design, oversight of all aspects of the study, reviewed data and wrote manuscript. NW, PY and XS: overall supervision of field work and training, and development of operational field manuals. FM: supervised field work and training of interviewers in rural country. RY: supervised field work and training of interviewers in urban county. NW, LF, PY and BW: conducted quality control supervisory visits and other quality control efforts; JF, RJB, AC, LF, MSL and NP: oversaw data entry, manual and electronic data review, and conducted data analysis. LH, LF, SC, MSL and RJB: responsible for financial supervision. FL, XL, FLv, CM, YT, WW, HW and LZ: provided key assistance with access and collaboration of eight hospitals, developed and reviewed the field manual for identifying eligible paediatric cancer cases, oversaw efforts to identify eligible pediatric cancer cases, oversaw abstracting of medical records, reviewed medical record abstracts and determined final diagnoses of paediatric cancer cases.
Funding All funding for this project was provided by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the US Public Health Service of the Department of Health and Human Services; cooperative agreements from the US Centers for Disease Control and Prevention (U01 GH0000029 and 5U 19 GH000636); and internal funding from the Chinese Center for Disease Control and Prevention.
Competing interests None declared.
Ethics approval The protocol was approved by the institutional ethics review committees including: the National Cancer Institute Special Studies Institutional Review Board (NCI SSIRB - 11CN165 for original and annual renewals); the US Centers for Disease Control and Prevention, which relied on the NCI SSIRB original and annual IRB approvals (CDC protocol 6140); and the Chinese Center for Disease Control and Prevention (CCDC protocol 201110 approved August 8, 2011). Informed written consent was obtained for all aspects of data collection (interviews and anthropometric measurements) from all subjects aged ≥18. Written assent was obtained from children under age 18. The participants all received certificates of appreciation; mothers received vouchers for purchasing groceries (US$ value = $15); children received memory sticks (US$ value = $7.60. Identification of pediatric cancers diagnosed during 1994-2013 in the catchment area of the original CIP study was carried out within each hospital and data collected were stripped of all personal identifying information before being provided to the Chinese CDC and other collaborators.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The study protocol, data collection instruments, field and coding manuals are available from the corresponding author upon request. If the full-scale study is funded, the findings would be shared with the subjects, public health officials and medical professionals through newsletters and other types of communication. The main results of the study will also be reported in peer-reviewed scientific journals, and at professional society meetings and international conferences. Qualified researchers can also contact the Steering Committee for the study and seek collaboration with study investigators in research projects that would use study data.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.